Catalyst Pharmaceutical Partners Inc buy Citigroup Inc.
Start price
07.11.25
/
50%
€18.50
Target price
07.11.26
€28.60
Performance (%)
4.35%
Price
19.01.26
€19.30
Summary
This prediction is currently active. With a performance of 4.35%, the BUY prediction by Citigroup_Inc_ for Catalyst Pharmaceutical Partners Inc is trending in the right direction. This prediction currently runs until 07.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 0.230% | 0.230% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Citigroup_Inc_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its price target raised by analysts at Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€15.01
14.03.24
14.03.24
€24.74
14.03.25
14.03.25
26.78%
15.03.25
15.03.25
